The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA

October 3rd, 2019

This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.  

Podbean App

Play this podcast on Podbean App